Atlas Trials

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

Clinical trial NCT05615415 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05615415
Sponsor
NYU Langone Health
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
Start date
2022-02-15
Primary completion
2026-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.